Hemophagocytic lymphohistiocytosis in a rheumatoid arthritis patient treated with infliximab

Internal Medicine

Volumn 51, Issue 6, 2012, Pages 655-657

  Oda, Yuzo ^a   Urushidani, Yoshinori ^a   Ooi, Shinji ^a   Endoh, Akira ^a   Nakamura, Rika ^a   Adachi, Koji ^a   Fukushima, Hiroko ^b  

^a MATSUE RED CROSS HOSPITAL   (Japan)

^b Division of Orthopaedic Surgery   (Japan)

Author keywords

Bacterial infection; Escherichia coli; Hemophagocytic lymphohistiocytosis; Infliximab; Rheumatoid arthritis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; COLONY STIMULATING FACTOR 1; FERRITIN; GAMMA INTERFERON; IMMUNOGLOBULIN; INFLIXIMAB; INTERLEUKIN 1BETA; INTERLEUKIN 6; MEROPENEM; METHYLPREDNISOLONE; PROCALCITONIN; SOLUBLE INTERLEUKIN 2 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DEATH; DROWSINESS; ESCHERICHIA COLI INFECTION; FEMALE; FEVER; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HISTIOCYTE; HUMAN; HUMAN TISSUE; MULTIPLE ORGAN FAILURE; PYELONEPHRITIS; RHEUMATOID ARTHRITIS;

AGED; ANTI-BACTERIAL AGENTS; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BONE MARROW; ESCHERICHIA COLI INFECTIONS; FATAL OUTCOME; FEMALE; HISTIOCYTES; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; METHYLPREDNISOLONE; PYELONEPHRITIS; THIENAMYCINS;

EID: 84858247117     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.51.5687     Document Type: Article

References (25)

1. Ishii E, Ohga S, Imashuku S, et al. Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol 86: 58-65, 2007.
2. Hara T, Honjo S, Miyazaki C, et al. Histiocytic hemophagocytosis in the bone marrow in children with sepsis and disseminated intravascular coagulation. Acta Paediatr Jpn 31: 335-339, 1989.
3. François B, Trimoreau F, Vignon P, Verger G, Gastinne H. Reactive hemophagocytic syndrome: a probably underestimated cause of thrombocytopenia in intensive care patients. Ann Fr Anesth Reanim 14: 514-516, 1995(in French with English abstract).
4. Miyamoto K, Yamada K, Kato F, et al. Autopsy case of infectionassociated hemophagocytic syndrome caused by E. coli-induced acute pyelonephritis. Nippon Naika Gakkai Zasshi 86: 1453-1455, 1997(in Japanese).
5. El Khoury N, Lassoued K, Pellé G, et al. Hemophagocytosis associated with Eschericia coli sepsis: a case report. Rev Méd Interne 24: 688-691, 2003(in French with English abstract).
6. Aouba A, De Bandt M, Aslangul E, Atkhen N, Patri B. Haemophagocytic syndrome in a rheumatoid arthritis patient treated with infliximab. Rheumatology 42: 800-802, 2003.
7. Chang KH, Tang LM, Lyu RK. Spontaneous Escherichia coli meningitis associated with hemophagocytic lymphohistiocytosis. J Formos Med Assoc 105: 756-759, 2003.
8. Asci G, Toz H, Ozkahya M, et al. High-dose immunoglobulin therapy in renal transplant recipients with hemophagocytic histiocytic syndrome. J Nephrol 19: 322-326, 2006.
9. Parmetier B, Hammel P, Bennani H, Vailla D, Lévy P, Ruszniewski P. Severe thrombocytopenia as single sign of hemophagocytosis in a patient with cirrhosis and lethal infection of ascites fluid by Eschericia coli. Gastroenterol Clin Biol 31: 967-969, 2007(in French with English abstract).
10. Romanan AV, Schneider R. Macrophage activation syndrome following initiation of etanercept in a child with systemic onset juvenile rheumatoid arthritis. J Rheumatol 30: 401-403, 2003.
11. Sarwar H, Espinoza LR, Gedalia A. Macrophage activation syndrome and etanercept in children with systemic juvenile rheumatoid arthritis. J Rheumatol 31: 623-624, 2004.
12. Stern A, Riley R, Buckley L. Worsening of macrophage activation syndrome in a patient with adult onset Still's disease after initiation of etanercept therapy. J Clin Rheumatol 7: 252-256, 2001.
13. Henzan T, Nagafuji K, Tsukamoto H, et al. Success with infliximab in treating refractory hemophagocytic lymphohistiocytosis. Am J Hematol 81: 59-61, 2006.
14. Makay B, Yilmaz S, Türkyilmaz Z, Ünal N, Ören H, Ünsal E. Etanercept for therapy-resistant macrophage activation syndrome. Pediatr Blood Cancer 9: 419-421, 2006.
15. Prahalad S, Bove KE, Dickens D, Lovell DJ, Grom AA. Etanercept in the treatment of macrophage activation syndrome. J Rheumatol 28: 2120-2124, 2001.
16. Ideguchi H, Ohno S, Takase K, Hattori H, Kirino Y, Takeno M. Successful treatment of refractory lupus-associated hemophagocytic lymphohistiocytosis with infliximab. Rheumatology 46: 1621-1622, 2007.
17. Kumakura S, Ishikura H, Umegae N, Yamagata S, Kobayashi S. Autoimmune associated hemophagocytic syndrome. Am J Med 102: 113-115, 1997.
18. Kumakura S, Ishikura H, Kondo M, et al. Autoimmune associated hemophagocytic syndrome. Mod Rheumatol 14: 205-215, 2004.
19. Risdall RJ, Brunning RD, Hernandez JI, Gordon DH. Bacteriaassociated hemophagocytic syndrome. Cancer 54: 2968-2972, 1984.
20. Henter JI, Horne AC, Aricó M, et al. Review HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48: 124-131, 2007.
21. Edner J, Rudd E, Zheng C, et al. Severe bacterial-associated hemophagocytic lymphohistiocytosis in an extremely premature infant. Acta Paediatrica 96: 1701-1706, 2007.
22. Verbsky JW, Grossman WJ. Hemophagocytic lymphohistiocytosis: diagnosis, pathophysiology, treatment, and future perspectives. Ann Med 38: 20-31, 2006.
23. Dinarello CA, Wollfe SM. The role of interleukin-1 in disease. N Engl J Med 14: 106-113, 1993.
24. Takahashi K, Kumakura S, Ishikura H, et al. Reactive hemophagocytosis in systemic lupus erythematosus. Intern Med 37: 550-553, 1998.
25. Ishii E, Ohga S, Aoki T, et al. Prognosis of children with virusassociated hemophagocytic syndrome and malignant histiocytosis: correlation with levels of serum interleukin-1 and tumor necrosis factor. Acta Haematol 85: 93-99, 1991.